UBS Bank Provides $150MM Credit Facility to Supernus Pharmaceuticals
Supernus Pharmaceuticals, entered into a credit line agreement with UBS Bank providing the company an uncommitted demand secured line of credit of up to $150 million, which can be drawn at any time.
February 15, 2023
Jack Khattar | Supernus Pharmaceuticals | UBS Bank
Ian Koplin